Notizie AIOM – anno XVII
Biden Cancer Initiative Suspends All Operations
July 15, 2019 - Today, the Biden Cancer Initiative announced it would suspend all operations. The Initiative, which launched on June 26, 2017, is an independent nonprofit organization that was built on the goals of the White House Cancer Moonshot program created by President ...Leggi tutto
Statement on the agency’s actions to tackle the epidemic of youth vaping and court ruling on application submission deadlines for certain tobacco products, including e-cigarettes
July 15, 2019 - Late last week, a U.S. District Court judge in Maryland issued a decision that, among other things, requires makers and importers of e-cigarettes and other electronic nicotine delivery systems (ENDS) and certain other tobacco products like cigars, pipe tobacco ...Leggi tutto
Twenty Oncology Practices Achieve ASCO’s QOPI® Certification in Second Quarter of 2019
July 16, 2019 - Twenty practices in three countries elevated their standard of care and achieved Quality Oncology Practice Initiative (QOPI®) Certification in the second quarter of this year. The American Society of Clinical Oncology, Inc. (ASCO®) commends these ...Leggi tutto
FDA Approval Sought for Enfortumab Vedotin for Urothelial Cancer
July 16, 2019 - A biologics license application (BLA) has been submitted to the FDA for enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer who have previously received a PD-1/PD-L1 inhibitor and who have received a platinum-containing ...Leggi tutto
FDA Approval Sought for Subcutaneous Daratumumab in Multiple Myeloma
July 12, 2019 - A supplemental biologics license application (sBLA) has been submitted to the FDA for a new subcutaneous formulation of daratumumab for the treatment of patients with multiple myeloma. The sBLA is based on findings from the phase III COLUMBA (MMY3012) study, ...Leggi tutto
PRAC recommends new measures to avoid dosing errors with methotrexate
July 12, 2019 - EMA’s safety committee (PRAC) is recommending new measures to avoid dosing errors that have led to some patients incorrectly taking methotrexate-containing medicines daily instead of weekly. The new measures include restricting who can prescribe these ...Leggi tutto